These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 32080953
1. Frequent homozygous deletion of Cdkn2a/2b in tremolite-induced malignant mesothelioma in rats. Okazaki Y, Misawa N, Akatsuka S, Kohyama N, Sekido Y, Takahashi T, Toyokuni S. Cancer Sci; 2020 Apr; 111(4):1180-1192. PubMed ID: 32080953 [Abstract] [Full Text] [Related]
2. Fibers in lung tissues of mesothelioma cases among miners and millers of the township of Asbestos, Quebec. Dufresne A, Harrigan M, Massé S, Bégin R. Am J Ind Med; 1995 Apr; 27(4):581-92. PubMed ID: 7793429 [Abstract] [Full Text] [Related]
3. An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments. Gamble JF, Gibbs GW. Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S154-86. PubMed ID: 18396365 [Abstract] [Full Text] [Related]
4. Rat model demonstrates a high risk of tremolite but a low risk of anthophyllite for mesothelial carcinogenesis. Aierken D, Okazaki Y, Chew SH, Sakai A, Wang Y, Nagai H, Misawa N, Kohyama N, Toyokuni S. Nagoya J Med Sci; 2014 Feb; 76(1-2):149-60. PubMed ID: 25130001 [Abstract] [Full Text] [Related]
5. Chrysotile, tremolite, and malignant mesothelioma in man. Churg A. Chest; 1988 Mar; 93(3):621-8. PubMed ID: 2830081 [Abstract] [Full Text] [Related]
6. Asbestos fibers contributing to the induction of human malignant mesothelioma. Suzuki Y, Yuen SR. Ann N Y Acad Sci; 2002 Dec; 982():160-76. PubMed ID: 12562635 [Abstract] [Full Text] [Related]
7. An updated evaluation of reported no-observed adverse effect levels for chrysotile, amosite, and crocidolite asbestos for lung cancer and mesothelioma. Beckett EM, Abelmann A, Roberts B, Lewis RC, Cheatham D, Miller EW, Hall E, Pierce JS. Crit Rev Toxicol; 2023 Nov; 53(10):611-657. PubMed ID: 38126124 [Abstract] [Full Text] [Related]
11. A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans. Garabrant DH, Pastula ST. Toxicol Appl Pharmacol; 2018 Dec 15; 361():127-136. PubMed ID: 30077661 [Abstract] [Full Text] [Related]
12. Comparison of Calidria chrysotile asbestos to pure tremolite: inhalation biopersistence and histopathology following short-term exposure. Bernstein DM, Chevalier J, Smith P. Inhal Toxicol; 2003 Dec 15; 15(14):1387-419. PubMed ID: 14648356 [Abstract] [Full Text] [Related]
13. Asbestos in the lungs of persons exposed in the USA. Langer AM, Nolan RP. Monaldi Arch Chest Dis; 1998 Apr 15; 53(2):168-80. PubMed ID: 9689804 [Abstract] [Full Text] [Related]
14. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type. Berman DW, Crump KS. Crit Rev Toxicol; 2008 Apr 15; 38 Suppl 1():49-73. PubMed ID: 18686078 [Abstract] [Full Text] [Related]
15. Iron overload signature in chrysotile-induced malignant mesothelioma. Jiang L, Akatsuka S, Nagai H, Chew SH, Ohara H, Okazaki Y, Yamashita Y, Yoshikawa Y, Yasui H, Ikuta K, Sasaki K, Kohgo Y, Hirano S, Shinohara Y, Kohyama N, Takahashi T, Toyokuni S. J Pathol; 2012 Nov 15; 228(3):366-77. PubMed ID: 22864872 [Abstract] [Full Text] [Related]
16. Evaluation of tremolite asbestos exposures associated with the use of commercial products. Finley BL, Pierce JS, Phelka AD, Adams RE, Paustenbach DJ, Thuett KA, Barlow CA. Crit Rev Toxicol; 2012 Feb 15; 42(2):119-46. PubMed ID: 22141364 [Abstract] [Full Text] [Related]